Author Archive

Nominations for 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship Open

We are pleased to welcome nominations for the 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship. The Lectureship celebrates early career researchers who have made significant contributions in the fields of medicinal chemistry and drug discovery.

Nominations will close 30 November 2020.

The recipient of the lectureship will receive a contribution of up to £1000 towards speaking at a conference in 2021. We recognise many researchers’ travel plans for 2021 are uncertain, and are flexible in accommodating speaking engagements at digital conferences.

Eligibility:
The lectureship is open to candidates who received their PhD in 2011 or later and who have made a significant contribution to medicinal chemistry in their early career, particularly if they have brought new ideas to drug discovery.

How you can nominate:
If you would like to nominate someone please email medchem-rsc@rsc.org with the following details:

  • Their name
  • Their affiliation
  • At least one paragraph explaining their achievements and why you think they should be considered

Additional supporting information, for example their CV, is very helpful in making a decision but is not mandatory for making a nomination.

Self-nominations are accepted but must be supported by a letter of support from your Head of Department or similar person at your institute.

Selection:
All qualified nominations will be considered and a short-list of candidates will be selected based on the information provided at nomination. The RSC Medicinal Chemistry Editorial Board will then vote to select the recipient and the winner will be announced in early 2021.

Past winners of the RSC Medicinal Chemistry Emerging Investigator Lectureship (previously named the MedChemComm Emerging Investigator Lectureship) include:

  • Dr Chandradhish Ghosh (Max Planck Institute of Colloids and Interfaces) – 2020
  • Dr. Amanda Hargrove (Duke University, USA) – 2019
  • Dr. Gonçalo Bernardes (University of Cambridge, UK) – 2018
  • Dr Laura H. Heitman (Leiden University, Netherlands) – 2017
  • Dr Alessio Ciulli (University of Dundee, UK) – 2016
  • Professor Richard Payne (University of Sydney, Australia) – 2015
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Register now for upcoming RSC Medicinal Chemistry Desktop Seminars

We’re excited to announce three upcoming RSC Medicinal Chemistry Desktop Seminars, featuring winners of the 2019 and 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship.

RSC Desktop Seminars are an initiative from the Royal Society of Chemistry to bring cutting-edge research directly to you! Now, more than ever, there is a crucial need for sharing research, and we’re pleased to present alongside Editorial Board members and Associate Editors, two RSC Medicinal Chemistry Emerging Investigator Lectureships in a digital format for the first time ever.

These seminars will cover a wide range of medicinal chemistry topics, from targeting infectious diseases to techniques for candidate identification and the chemistry of drug design. Be sure to register for each seminar individually at the links below!

30th September:

Chandradhish Ghosh

Dr. Chandradhish Ghosh

Sylvie Garneau-Tsodikova

Professor Sylvie Garneau-Tsodikova

Dr. Chandradhish Ghosh, 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship recipient, (Max Planck Institute of Colloids and Interfaces)
“Fantastic bugs and how to kill them”

Professor Sylvie Garneau-Tsodikova, RSC Medicinal Chemistry Associate Editor, (University of Kentucky)
Infectious disease research/publishing in time of a pandemic”

Introductions will be given by RSC Medicinal Chemistry Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Jennifer Lee.

See more information about the speakers and register here!

7th October:

Amanda Hargrove

Professor Amanda Hargrove

Professor Jean-Louis Reymond

Professor Jean-Louis Reymond

Professor Amanda Hargrove, 2019 MedChemComm Emerging Investigator Lectureship recipient and ChemComm Advisory Board member, (Duke University)
“Modulating the conformation and function of disease-relevant RNA with small molecules”

Professor Jean-Louis Reymond, RSC Medicinal Chemistry Editorial Board member, (University of Bern)
“GDB and the chemical space: enumeration, visualization, synthesis”

Introductions will be given by RSC Medicinal Chemistry Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Jennifer Lee.

Registration is open now.

14th October:

Dr. Yoshinori Ikeura

Dr. Yoshinori Ikeura

Sally-Ann Poulsen

Professor Sally-Ann Poulsen

Professor Sally-Ann Poulsen, RSC Medicinal Chemistry Associate Editor, (Griffith University)
“The elephant in the room – Fragment screening using mass spectrometry”

Dr. Yoshinori Ikeura, RSC Medicinal Chemistry Editorial Board member, (Axcelead Drug Discovery Partners)
“The chemist’s contribution to the modern era in drug discovery”

Introductions will be given by RSC Medicinal Chemistry Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Hiromitsu Urakami.

Registration is now open, and you can sign up here!

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

2020 RSC Medicinal Chemistry Lectureship Winner

Congratulations to Dr. Chandradhish Ghosh, the recipient of the 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship!

Chandradhish GhoshThe Lectureship was open to any candidate who received their PhD in 2010 or later and has made a significant contribution to medicinal chemistry in their early career. The RSC Medicinal Chemistry Editorial Board selected Dr. Ghosh, from Max Planck Institute of Colloids and Interfaces, Germany, from a short-list of nominees.

Many congratulations to Dr. Ghosh for winning the lectureship.

When he was informed of his selection, Dr. Ghosh said:

I feel humbled to be recognized by scientists who inspire me. It motivates me to strive harder to solve the problems of human diseases. This would not have been possible without the support of fantastic mentors, colleagues, collaborators, teachers, friends and family.”

About Chandradhish

Dr. Chandradhish Ghosh performed his doctoral studies at Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, under the supervision of Prof. Jayanta Haldar, after first earning his MSc in Chemistry at the University of Delhi. Since 2017, he has been working at the Max Planck Institute for Colloids and Interfaces, in the group of Prof. Peter H. Seeberger. His current work focusses on targeting neglected tropical diseases.

His doctoral work on membrane-active small molecules against drug-resistant pathogens has led to an anti-Ebola drug candidate. He has contributed to the sum of knowledge in the field by the publication of several highly cited reviews. He has won several awards, including the prestigious Gandhian Young Technological Innovation Award in 2015.

To show the range of his scientific work, some of Dr. Ghosh’s recent works are below:

A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics

Med. Chem. Commun., 2017, 8, 516-533

l-Lysine based lipidated biphenyls as agents with anti-biofilm and anti-inflammatory properties that also inhibit intracellular bacteria

Chem. Commun., 2017, 53, 8427-8430

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)